When intuition falters: repeated testing accuracy during an epidemic.


Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 14 04 2021
accepted: 22 06 2021
pubmed: 30 7 2021
medline: 3 9 2021
entrez: 29 7 2021
Statut: ppublish

Résumé

Widespread, repeated testing using rapid antigen tests to proactively detect asymptomatic SARS-CoV-2 infections has been a promising yet controversial topic during the COVID-19 pandemic. Concerns have been raised over whether currently authorized lateral flow tests are sufficiently sensitive and specific to detect enough infections to impact transmission whilst minimizing unnecessary isolation of false positives. These concerns have often been illustrated using simple, textbook calculations of positivity rates and positive predictive value assuming fixed values for sensitivity, specificity and prevalence. However, we argue that evaluating repeated testing strategies requires the consideration of three additional factors: new infections continue to arise depending on the incidence rate, isolating positive individuals reduces prevalence in the tested population, and each infected individual is tested multiple times during their infection course. We provide a simple mathematical model with an online interface to illustrate how these three factors impact test positivity rates and the number of isolating individuals over time. These results highlight the potential pitfalls of using inappropriate textbook-style calculations to evaluate statistics arising from repeated testing strategies during an epidemic.

Identifiants

pubmed: 34322830
doi: 10.1007/s10654-021-00786-w
pii: 10.1007/s10654-021-00786-w
pmc: PMC8318052
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

749-752

Subventions

Organisme : NIH HHS
ID : DP5 OD028145
Pays : United States
Organisme : Wellcome Trust
ID : 210758/Z/18/Z
Pays : United Kingdom
Organisme : NIH Office of the Director
ID : DP5-OD028145
Organisme : NIGMS NIH HHS
ID : U54 GM088558
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : U54GM088558
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

N Engl J Med. 1999 Jul 8;341(2):131
pubmed: 10409035
N Engl J Med. 2020 Nov 26;383(22):e120
pubmed: 32997903
BMJ. 2021 Mar 19;372:n706
pubmed: 33741566
Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705
pubmed: 33760236

Auteurs

James A Hay (JA)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. jhay@hsph.harvard.edu.

Joel Hellewell (J)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.

Xueting Qiu (X)

Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH